Cardio Diagnostics Holdings, Inc. (CDIOW) community

CDIOWNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIO

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/30

$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $4.94MP/E –Yield –

Community

Notes and questions about Cardio Diagnostics from other investors

No posts about CDIOW yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Cardio Diagnostics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on May 13, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CDIOW.

Compare: CDIOW vs VRAX · CDIOW vs ADTX · CDIOW vs AWHL · CDIOW vs PRFX · CDIOW vs BDPT

Revenue growth-57.5% · median 310.0%

Operating margin-43737.5% · median -4059.4%

Net margin-43832.5% · median -5885.3%

Company	Revenue	Growth
AWHL	$170.00K	–
BDPT	$25.56K	+694.1%
CDIOW	$14.83K	-57.5%
ADTX	$14.34K	-74.1%
VRAX	–	–
PRFX	–	–

Company

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
Fiscal year ends: December 31
Employees: 7
Auditor: Prager Metis CPAs, LLC
SEC CIK: 1870144

Advertisement
300 × 250